Are you Dr. Ward?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 63 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
Dhmc Section Of Neurology
Lebanon, NH 03756Phone+1 603-650-8664Fax+1 603-650-6233
Summary
- Dr. Thomas Ward, MD is a board certified neurologist in Lebanon, New Hampshire. He is currently licensed to practice medicine in New Hampshire and Vermont. He is affiliated with White River Junction Veterans Affairs Medical Center.
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Neurology, 1982 - 1985
Albany Medical CenterResidency, Internal Medicine, 1980 - 1982
Geisel School of Medicine at DartmouthClass of 1980
Certifications & Licensure
VT State Medical License 1982 - 2026
NH State Medical License 1985 - 2023- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Publications & Presentations
PubMed
- 63 citationsSex Matters: Evaluating Sex and Gender in Migraine and Headache ResearchB. Lee Peterlin, Saurabh Gupta, Thomas N. Ward, E. Anne MacGregor
Headache. 2011-06-01 - 39 citationsPsychosocial factors of relevance to sex and gender studies in headache.Todd A. Smitherman, Thomas N. Ward
Headache. 2011-06-01 - 41 citationsA retrospective, comparative study on the frequency of abuse in migraine and chronic daily headache.B. Lee Peterlin, Thomas N. Ward, Jeffrey Lidicker, Morris Levin
Headache. 2007-03-01
Press Mentions
Bringing Focus to the Issue: Dr. Elizabeth Loder on Gender in MedicineOctober 15th, 2019
New Drugs Might Prevent Migraines Before They Start - US NewsJune 18th, 2015
Terminating Migraine-Associated Allodynia Using Oral Suspension Diclofenac: A Prospective Non-Randomized Drug TrialFebruary 23rd, 2017
